The impact of the COVID-19 pandemic on the non-government alcohol and other drug sector: future implications
The Drug Policy Modelling Program (DPMP) at the University of New South Wales has released a report on ‘The impact of the COVID-19 pandemic on the non-government alcohol and other drug sector: future implications’. NADA commissioned DPMP to undertake the study to explore the impact of the COVID-19 pandemic on it’s members and provide advice on the immediate, medium and long-term actions that need to follow.
COVID-19 has demanded significant changes to funding arrangements, leadership and strategic planning, the types of care provided, and workforce requirements and support. It provides the opportunity to review all aspects of non government AOD treatment services, including the ways in which services are commissioned and funded by governments, and how services are supported, led, and delivered.
The actions resulting from the study are directed at treatment providers, NADA, and non government AOD funders. Whilst many of these actions have commenced, some are longstanding issues impacting on the sector, such as the underfunding of AOD treatment, and recruitment and retention of staff. NADA is committed to working with sector to implement the actions.
NADA proudly acknowledges the Gadigal people of the Eora Nation as the custodians of the land on which our office stands. We extend this acknowledgement to all Aboriginal and Torres Strait Islander people across Australia and pay our respects to Elders past, present and future.
NADA is accredited under the Australian Services Excellence Standards (ASES) a quality framework certified by Quality Innovation and Performance (QIP).